- Home
- App Analytics
- Guía de Linfoma de GELTAMO
- Guía de Linfoma de GELTAMO Vs. Trialing
Guía de Linfoma de GELTAMO vs Trialing Uso e estatísticas
This mobile app with Interactive Guides in Lymphoma has been developed by the Spanish Research Group specialized in Lymphomas (GELTAMO).
These interactive guides have been prepared and reviewed by leading lymphoma experts and are grounded in evidence-based medicine findings, providing a comprehensive set of recommendations for medical professionals to help patients with the best care options.
This app must be able to be used in mobile devices by medical professionals in geographic areas without Internet connection and medical centers isolated installations without Internet connection such us nuclear medicine, radiotherapy rooms among others.
- Apple App Store
- Gratuitos
- Médico
Ranking da Loja
- -
Trialing is a platform that helps doctors easily find the most suitable clinical trial for their patients and establish direct contact with the principal investigator. No delays or bureaucracy.
We work with reviewed, organized, and categorized data. At Trialing, we don't settle for just showing the features of clinical trials; we go into detail.
Thanks to our network of healthcare professionals, we know precisely which hospitals are recruiting. This way, you can choose the most appropriate hospital to refer your patient to.
At Trialing, we offer the opportunity to contact the destination center directly: no intermediaries and no delays.
- Apple App Store
- Gratuitos
- Médico
Ranking da Loja
- -
Guía de Linfoma de GELTAMO versus Trialing comparação de classificação
Compare a tendência de classificação de Guía de Linfoma de GELTAMO nos últimos 28 dias versus Trialing
Classificação
Nenhum dado disponível
Comparação da classificação de Guía de Linfoma de GELTAMO vs. Trialing por país
Compare a tendência de classificação de Guía de Linfoma de GELTAMO nos últimos 28 dias versus Trialing
Nenhum dado para exibir
Faça comparações com qualquer site com o nosso teste grátis
Guía de Linfoma de GELTAMO VS.
Trialing
13ezembro d, 2024